SABCS 2016

Area: Oncology

Location: San Antonio, United States

Date: December 6 to December 10

Description:

San Antonio Breast Cancer Symposium.


Search in Scientific Content:
Date
Filters:
PrECOG 010
5:54

PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo in Post-Menopausal Women with Hormone-Receptor Positive, HER2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy

Presenter: Noah S. Kornblum
Oncology : Breast Cancer
A Randomiz
9:16

A Randomized, Double-blinded, Placebo-controlled Clinical Trial: Results from NRG Oncology/NSABP B-42

Presenter: Eleftherios P. Mamounas
Oncology : Breast Cancer
Efficacy a
8:02

Efficacy and tolerability of veliparib in combination; Phase 2 Study

Presenter: Hyo Sook Han
Oncology : Breast Cancer
Whole exom
10:13

Whole exome and transcriptome sequencing of resistant ER+ metastatic breast cancer (MBC)

Presenter: Ofir Cohen
Oncology : Breast Cancer
Biological
10:25

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cance

Presenter: Sara Hurvitz
Oncology : Breast Cancer
Adjuvant I
8:21

Adjuvant Ibandronate in early breast cancer First results of the TEAM Iib trial

Presenter: Sabine Linn
Oncology : Breast Cancer

Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive Breast Cancer treated with Neoadjuvant Therapy of Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP) with or without Concurrent Estrogen Deprivation Thera

Presenter: Mothaffar Rimawi
Oncology : Breast Cancer
Aromatase
6:58

Aromatase inhibitors and endothelial function: is there an association with early cardiovascular disease?

Presenter: Anna Blaes
Oncology : Breast Cancer
Menopausal
5:27

Menopausal symptoms as predictors of long-term adherence in the International Breast Cancer Intervention Study (IBIS-1)

Presenter: Samuel G. Smith
Oncology : Breast Cancer
Double-bli...
7:06

Double-blind Concordance Study of Breast Cancer Treatment, Recommendations Between Manipal Multidisciplinary Tumor Board and an Artificial Intelligence Advisor for Oncology, IBM’s Watson For Oncology

Presenter: Somashekhar S.P
Oncology : Breast Cancer
Biological
3:36

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenop. patients with HR+, HER2- breast cancerBiological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenop. patients with HR+, HER2- breast

Presenter: Sara Hurvitz
Oncology : Breast Cancer
Breast can
4:05

Breast cancer initiative 2.5 (BCI2.5): A framework for systematic improvement in global breast cancer outcomes

Presenter: Benjamin O. Anderson
Oncology : Breast Cancer
Treatment
6:17

Treatment of metastatic breast cancer in older adults

Presenter: Etienne Brain
Oncology : Breast Cancer
Highlights
9:53

Highlights of the congress (Extended studies)

Presenter: Matteo Lambertini
Oncology : Breast Cancer
IMENEO: In
4:23

IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy

Presenter: Anthony Lucci
Oncology : Breast Cancer
Primary an
7:33

Primary analysis of PERTAIN: A randomized, two-arm, open-label, multicenter phase II trial

Presenter: Mothaffar Rimawi
Oncology : Breast Cancer
Safety and
6:56

Safety and efficacy of trastuzumab emtansine in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study

Presenter: Filippo Montemurro
Oncology : Breast Cancer
Breast can
3:46

Breast cancer health disparities. Women from different ethnic groups: Biology vs. other factors.

Presenter: Melissa Bondy
Oncology : Breast Cancer
Advances i
6:06

Advances in metastatic breast cancer with Cdk 4/6 inhibitors, PI3 inhibitors

Presenter: Matthew P. Goetz
Oncology : Breast Cancer
Phase II t
3:41

Phase II trial of pertuzumab, trastuzumab, and nab-paclitaxel in patients with HER2 overexpressing locally advanced or inflammatory breast cancer or untreated stage IV metastatic breast cancer

Presenter: George Somlo
Oncology : Breast Cancer

ESMO 2020

2020-09-19 - 2020-09-21
Online, Virtual

ASCO 2020

2020-05-29 - 2020-05-31
Online, Virtual

ESMO 2019

2019-09-27 - 2019-10-01
Barcelona, Spain

ASCO 2019

2019-05-31 - 2019-06-04
Chicago, United States

EADO 2019

2019-04-24 - 2019-04-27
Paris, France

BCC 2019

2019-03-20 - 2018-03-23
Vienna, Austria

SABCS 2018

2018-12-04 - 2018-12-08
San Antonio, United States

ESMO 2018

2018-10-19 - 2018-10-23
Munich, Germany

ASCO 2018

2018-06-01 - 2018-06-05
Chicago, United States